nach oben

Erschienen in:

28.03.2024

Implications of vascular depression for successful cognitive aging in HIV Disease

verfasst von: Andrea I. Mustafa, Ilex Beltran-Najera, Darrian Evans, Alexandria Bartlett, Vonetta M. Dotson, Steven Paul Woods

Erschienen in: Journal of NeuroVirology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Although older adults with HIV are at high risk for mild neurocognitive disorders, a subset experience successful cognitive aging (SCA). HIV is associated with an increased risk of vascular depression (VasDep), which can affect cognitive and daily functioning. The current study examined whether VasDep impedes SCA among older adults with HIV. 136 persons with HIV aged 50 years and older were classified as either SCA+ (n = 37) or SCA- (n = 99) based on a battery of demographically adjusted neurocognitive tests and self-reported cognitive symptoms. Participants were also stratified on the presence of vascular disease (e.g., hypertension) and current depression as determined by the Composite International Diagnostic Interview and the Depression/Dejection scale of the Profile of Mood States. A Cochran-Armitage test revealed a significant additive effect of vascular disease and depression on SCA in this sample of older adults with HIV (z = 4.13, p <.0001). Individuals with VasDep had the lowest frequency of SCA+ (0%), which differed significantly from the group with only vascular disease (30%, OR = 0.04, CI = 0.002,0.68)) and the group with neither vascular disease nor depression (47% OR = 0.02, CI = 0.33,0.001). Findings were not confounded by demographics, HIV disease severity, or other psychiatric and medical factors (ps > 0.05). These data suggest that presence of VasDep may be a barrier to SCA in older adults with HIV disease. Prospective, longitudinal studies with neuroimaging-based operationalizations of VasDep are needed to further clarify this risk factor’s role in the maintenance of cognitive and brain health in persons with HIV disease.

Aguero-Torres H, von Strauss E, Viitanen M, Winblad B, Fratiglioni L (2001) Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. J Clin Epidemiol 54(8):795–801. https://doi.org/10.1016/s0895-4356(00)00371-1CrossRefPubMed

Aizenstein HJ, Baskys A, Boldrini M, Butters MA, Diniz BS, Jaiswal MK, Jellinger KA, Kruglov LS, Meshandin IA, Mijajlovic MD, Niklewski G, Pospos S, Raju K, Richter K, Steffens DC, Taylor WD, Tene O (2016) Vascular depression consensus report - a critical update. BMC Med 14(1):161. https://doi.org/10.1186/s12916-016-0720-5CrossRefPubMedPubMedCentral

Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997) Vascular depression’ hypothesis. Arch Gen Psychiatry 54(10):915–922. https://doi.org/10.1001/archpsyc.1997.01830220033006CrossRefPubMed

American Psychiatric Association (2000) Diagnostic and statistical Manual of Mental disorders Fourth Edition text revision (DSM-IV-TR). American Psychiatric Association, Washington DC. https://doi.org/10.1176/appi.books.9780890423349CrossRef

Armitage P (1955) Tests for linear trends in proportions and frequencies. Biometrics 11:375–386. https://doi.org/10.2307/3001775CrossRef

Babu H, Ambikan AT, Gabriel EE, Svensson Akusjarvi S, Palaniappan AN, Sundaraj V, Mupanni NR, Sperk M, Cheedarla N, Sridhar R, Tripathy SP, Nowak P, Hanna LE, Neogi U (2019) Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long-term suppressive antiretroviral therapy. Front Immunol.;10:1965. https://doi.org/10.3389/fimmu.2019.01965

Basavaraj KH, Navya MA, Rashmi R (2010) Quality of life in HIV/AIDS. Indian J Sex Transm Dis AIDS 31(2):75–80. https://doi.org/10.4103/2589-0557.74971CrossRefPubMedPubMedCentral

Beltran-Najera I, Mustafa A, Warren D, Salling Z, Misiura M, Woods SP, Dotson VM (2023) Elevated frequency and everyday functioning implications of vascular depression in persons with HIV disease. J Psychiatr Res 160:78–85. https://doi.org/10.1016/j.jpsychires.2023.02.003CrossRefPubMedPubMedCentral

Bloch M (2018) Frailty in people living with HIV. AIDS Res Ther 15(1):19. https://doi.org/10.1186/s12981-018-0210-2CrossRefPubMedPubMedCentral

Bloch M, Kamminga J, Jayewardene A, Bailey M, Carberry A, Vincent T, Quan D, Maruff P, Brew B, Cysique LA (2016) A screening strategy for HIV-associated neurocognitive disorders that accurately identifies patients requiring neurological review. Clin Infect Dis 63(5):687–693. https://doi.org/10.1093/cid/ciw399CrossRefPubMedPubMedCentral

Bogoian HR, Dotson VM (2022) Vascular depression in Black americans: a systematic review of the construct and its cognitive, functional, and psychosocial correlates. Clin Neuropsychol 36(2):431–461. https://doi.org/10.1080/13854046.2021.1933188CrossRefPubMed

Bonelli RM, Cummings JL (2007) Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci 9(2):141–151. https://doi.org/10.31887/DCNS.2007.9.2/rbonelliCrossRefPubMedPubMedCentral

Bryant VE, Whitehead NE, Burrell LE, Dotson VM, Cook RL, Malloy P, Devlin K, Cohen RA (2015) Depression and apathy among people living with HIV: implications for treatment of HIV-associated neurocognitive disorders. AIDS Behav 19(8):1430–1437. https://doi.org/10.1007/s10461-014-0970-1CrossRefPubMedPubMedCentral

Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK, HNRC group (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26(3):307–319. https://doi.org/10.1080/13803390490510031CrossRefPubMed

Casaletto KB, Umlauf A, Beaumont J, Gershon R, Slotkin J, Akshoomoff N, Heaton RK (2015) Demographically corrected normative standards for the English version of the NIH Toolbox Cognition Battery. J Int Neuropsychol Soc 21:378–391. https://doi.org/10.1017/S1355617715000351CrossRefPubMedPubMedCentral

Castilho JL, Rebeiro PF, Shepherd BE, Nash R, Adams RS, Turner M, Furukawa SS, Hulgan T, Koethe JR, Sterling TR (2020) Mood disorders and increased risk of non-communicable disease in adults with HIV. J Acquir Immune Defic Syndr 83(4):397–404. https://doi.org/10.1097/QAI.0000000000002269CrossRefPubMedPubMedCentral

Centers for Disease Control and Prevention (CDC). HIV in the United States by age (2022) Retrieved from https://www.cdc.gov/hiv/group/age/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fhiv%2Fgroup%2Fage%2Folderamericans%2Findex.html

Chichetto NE, Kundu S, Freiberg MS, Koethe JR, Butt AA, Crystal S, So-Armah KA, Cook RL, Braithwaite RS, Justice AC, Fiellin DA, Khan M, Bryant KJ, Gaither JR, Barve SS, Crothers K, Bedimo RJ, Warner A, Tindle HA, Veterans Aging Cohort Study (2021) Association of syndemic unhealthy alcohol use, smoking, and depressive symptoms on incident cardiovascular disease among veterans with and without HIV-infection. AIDS Behav 25(9):2852–2862. https://doi.org/10.1007/s10461-021-03327-4CrossRefPubMedPubMedCentral

Cysique LA, Brew BJ (2019) Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm. J Neurovirol 25(5):710–721. https://doi.org/10.1007/s13365-018-0706-5CrossRefPubMed

Deeks SG, Tracy R, Douek DC (2013) Systemic effects of inflammation on health during chronic HIV infection. Immunity 39(4):633–645. https://doi.org/10.1016/j.immuni.2013.10.001CrossRefPubMedPubMedCentral

Deng L, Zhang X, Gao Y, Turner D, Qian F, Lu H, Vermund SH, Zhang Y, Qian HZ (2021) Association of HIV infection and cognitive impairment in older adults: a meta-analysis. Ageing Res Rev 68:101310. https://doi.org/10.1016/j.arr.2021.101310CrossRefPubMedPubMedCentral

Derry HM, Johnston CD, Burchett CO, Brennan-Ing M, Karpiak S, Zhu YS, Siegler EL, Glesby MJ (2022) Links between inflammation, mood, and physical function among older adults with HIV. J Gerontol B Psychol Sci Soc Sci 77(1):50–60. https://doi.org/10.1093/geronb/gbab027CrossRefPubMed

DeVaughn S, Müller-Oehring EM, Markey B, Bronte-Stewart HM, Schulte T (2015) Aging with HIV-1 infection: motor functions, cognition, and attention–a comparison with Parkinson’s disease. Neuropsychol Rev 25(4):424–438. https://doi.org/10.1007/s11065-015-9305-xCrossRefPubMedPubMedCentral

Dew MA, Becker JT, Sanchez J, Caldararo R, Lopez OL, Wess J, Dorst SK, Banks G (1997) Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med 27(2):395–409. https://doi.org/10.1017/s0033291796004552CrossRefPubMed

Dotson VM, Zonderman AB, Kraut MA, Resnick SM (2013) Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women. Int J Geriatr Psychiatry 28(1):66–74. https://doi.org/10.1002/gps.3791CrossRefPubMed

Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon D, Paton NI, Prineas RJ, Neaton JD, Group ISS (2012) Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS ONE 7(9):e44454. https://doi.org/10.1371/journal.pone.0044454CrossRefPubMedPubMedCentral

Erlandson KM, Wilson MP, MaWhinney S, Rapaport E, Liu J, Wilson CC, Rahkola JT, Janoff EN, Brown TT, Campbell TB, Jankowski CM (2021) The impact of moderate or high-intensity combined exercise on systemic inflammation among older persons with and without HIV. J Infect Dis 223(7):1161–1170. https://doi.org/10.1093/infdis/jiaa494CrossRefPubMed

Fazeli PL, Woods SP, Vance DE (2020) Successful functional aging in middle-aged and older adults with HIV. AIDS Behav 24(6):1592–1598. https://doi.org/10.1007/s10461-019-02635-0CrossRefPubMedPubMedCentral

Fazeli PL, Willig AL, Oliveira V, Buford TW, Vance DE, Burkholder G, Crane HM, Horvat Davey C, Fleming J, Webel AR (2023) The association between objectively-measured physical activity and cognitive functioning in middle-aged and older people living with HIV. AIDS Behav 27(4):1199–1210. https://doi.org/10.1007/s10461-022-03857-5CrossRefPubMed

Ferrucci L, Fabbri E, Inflammageing (2018) Chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15(9):505–522. https://doi.org/10.1038/s41569-018-0064-2CrossRefPubMedPubMedCentral

Field-Fote E (2019) Mediators and moderators, confounders, and covariates: exploring the variables that illuminate or obscure the active ingredients in neurorehabilitation. J Neurol Phys Ther 43(2):83–84. https://doi.org/10.1097/NPT.0000000000000275CrossRefPubMed

González HM, Tarraf W, Whitfield K, Gallo JJ (2012) Vascular depression prevalence and epidemiology in the United States. J Psychiatr Res 46(4):456–461. https://doi.org/10.1016/j.jpsychires.2012.01.011CrossRefPubMedPubMedCentral

Grace J, Malloy PF (2001) Frontal systems Behavior Scale. Professional manual. Psychological Assessment Resources, Inc., Lutz, FL

Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53(11):1120–1126. https://doi.org/10.1093/cid/cir627CrossRefPubMed

Guha A, Brier MR, Ortega M, Westerhaus E, Nelson B, Ances BM (2016) Topographies of cortical and subcortical volume loss in HIV and aging in the cART era. J Acquir Immune Defic Syndr 73(4):374–383. https://doi.org/10.1097/QAI.0000000000001111CrossRefPubMedPubMedCentral

Heaton RK, Kirson D, Velin RA, Grant I, the HNRC Group (1994) The utility of clinical ratings for detecting cognitive change in HIV infection. In: Grant I, Martin A (eds) Neuropsychology of HIV infection. Oxford University Press, New York, pp 188–206

Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, Wolfson T, Velin R, Marcotte TD, Hesselink JR, Jernigan TL, Chandler J, Wallace M, Abramson I (1995) The HNRC 500: neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1(3):231–251. https://doi.org/10.1017/S1355617700000230

Ibeneme SC, Uwakwe VC, Myezwa H, Irem FO, Ezenwankwo FE, Ajidahun TA, Ezuma AD, Okonkwo UP, Fortwengel G (2022) Impact of exercise training on symptoms of depression, physical activity level and social participation in people living with HIV/AIDS: a systematic review and meta-analysis. BMC Infect Dis 22(1):469. https://doi.org/10.1186/s12879-022-07145-4CrossRefPubMedPubMedCentral

Iudicello JE, Woods SP, Deutsch R, Grant I, HIV Neurobehavioral Research Program Hnrp Group (2012) Combined effects of aging and HIV infection on semantic verbal fluency: a view of the cortical hypothesis through the lens of clustering and switching. J Clin Exp Neuropsychol 34(5):476–488. https://doi.org/10.1080/13803395.2011.651103CrossRefPubMedPubMedCentral

Jellinger KA (2021) Pathomechanisms of vascular depression in older adults. Int J Mol Sci 23(1). https://doi.org/10.3390/ijms23010308

Kirton JW, Resnick SM, Davatzikos C, Kraut MA, Dotson VM (2014) Depressive symptoms, symptom dimensions, and white matter lesion volume in older adults: a longitudinal study. Am J Geriatr Psychiatry 22(12):1469–1477. https://doi.org/10.1016/j.jagp.2013.10.005CrossRefPubMed

Krishnan KR, Hays JC, Blazer DG (1997) MRI-defined vascular depression. Am J Psychiatry 154(4):497–501. https://doi.org/10.1176/ajp.154.4.497CrossRefPubMed

Kuhn T, Kaufmann T, Doan NT, Westlye LT, Jones J, Nunez RA, Bookheimer SY, Singer EJ, Hinkin CH, Thames AD (2018) An augmented aging process in brain white matter in HIV. Hum Brain Mapp 39(6):2532–2540. https://doi.org/10.1002/hbm.24019CrossRefPubMedPubMedCentral

Langebeek N, Kooij KW, Wit FW, Stolte IG, Sprangers MAG, Reiss P, Nieuwkerk PT, AGEhIV Cohort Study Group (2017) Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals. AIDS 31(10):1471–1481. https://doi.org/10.1097/qad.0000000000001511CrossRefPubMed

Levy ME, Anastos K, Levine SR, Plankey M, Castel AD, Molock S, Sen S, Asch FM, Milam J, Aouizerat B, Weber KM, Golub ET, Kaplan RC, Kassaye S (2020) Depression and psychosocial stress are associated with subclinical carotid atherosclerosis among women living with HIV. J Am Heart Assoc 9(13):e016425. https://doi.org/10.1161/JAHA.120.016425CrossRefPubMedPubMedCentral

Malaspina L, Woods SP, Moore DJ, Depp C, Letendre SL, Jeste D, Grant I, The HIV Neurobehavioral Research Programs (HNRP) Group (2011) Successful cognitive aging in persons living with HIV infection. J Neurovirol 17(1):110–119. https://doi.org/10.1007/s13365-010-0008-zCrossRefPubMed

Mayo NE, Brouillette M, Nadeau L, Dendukuri N, Harris M, Smaill F, Smith G, Thomas R, Fellows LK (2022) Investigators from the positive Brain Health now Study. A longitudinal view of successful aging with HIV: role of resilience and environmental factors. Qual Life Res 31(4):1135–1145. https://doi.org/10.1007/s11136-021-02970-7CrossRefPubMed

McCutchan JA, Marquie-Beck JA, Fitzsimons CA, Letendre SL, Ellis RJ, Heaton RK, Wolfson T, Rosario D, Alexander TJ, Marra C, Ances BM, Grant I (2012) Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology 78(7):485–492. https://doi.org/10.1212/WNL.0b013e3182478d64CrossRefPubMedPubMedCentral

McIntosh EC, Tureson K, Rotblatt LJ, Singer EJ, Thames AD (2021) HIV, vascular risk factors, and cognition in the combination antiretroviral therapy era: a systematic review and meta-analysis. J Int Neuropsychol Soc 27(4):365–381. https://doi.org/10.1017/S1355617720001022CrossRefPubMed

McNair PM, Lorr M, Droppleman LF (1981) POMS manual, 2nd edn. Educational and Industrial Testing Service, San Diego

Miller PE, Budoff M, Zikusoka M, Li X, Palella F Jr, Kingsley LA, Witt MD, Sharrett AR, Jacobson LP, Post WS (2014) Comparison of racial differences in plaque composition and stenosis between HIV-positive and HIV-negative men from the Multicenter AIDS Cohort Study. Am J Cardiol 114(3):369–375. https://doi.org/10.1016/j.amjcard.2014.04.049CrossRefPubMedPubMedCentral

Monteiro-Junior RS, de Maciel-Pinheiro T, da Matta Mello Portugal P, da Silva Figueiredo E, Terra LF, Carneiro R, Rodrigues LSF, Nascimento VD, Deslandes OJM, Laks AC (2018) Effect of exercise on inflammatory profile of older persons: systematic review and meta-analyses. J Phys Act Health 15(1):64–71. https://doi.org/10.1123/jpah.2016-0735CrossRefPubMed

Moore RC, Fazeli PL, Jeste DV, Moore DJ, Grant I, Woods SP, The HIV Neurobehavioral Research Program (HNRP) Group (2014) Successful cognitive aging and health-related quality of life in younger and older adults infected with HIV. AIDS Behav 18(6):1186–1197. https://doi.org/10.1007/s10461-014-0743-xCrossRefPubMedPubMedCentral

Moore DJ, Fazeli PL, Moore RC, Woods SP, Letendre SL, Jeste DV, Grant I, The HIV Neurobehavioral Research Program (HNRP) Group (2018) Positive psychological factors are linked to successful cognitive aging among older persons living with HIV/AIDS. AIDS Behav 22(5):1551–1561. https://doi.org/10.1007/s10461-017-2001-5CrossRefPubMedPubMedCentral

Müller-Oehring EM, Hong JY, Poston KL, Brontë-Stewart HM, Sullivan EV, McGlynn L, Schulte T (2022) Neurofunctional characteristics of executive control in older people with HIV infection: a comparison with Parkinson’s disease. Brain Imaging Behav 16(4):1776–1793. https://doi.org/10.1007/s11682-022-00645-6CrossRefPubMedPubMedCentral

Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett S, Ristola M, Ross MJ, Shlipak MG, Tracy R, Neaton JD (2010) Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 201(12):1788–1795. https://doi.org/10.1086/652749CrossRefPubMed

Nyenhuis DL, Yamamoto C, Luchetta T, Terrien A, Parmentier A (1999) Adult and geriatric normative data and validation of the Profile of Mood States. J Clin Psychol 55(1):79–86. https://doi.org/10.1002/(SICI)1097-4679(199901)55:1%3C79::AID-JCLP8%3E3.0.CO;2-7CrossRefPubMed

Oursler KK, Goulet JL, Crystal S, Justice AC, Crothers K, Butt AA, Rodriguez-Barradas MC, Favors K, Leaf D, Katzel LI, Sorkin JD (2011) Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the veterans Aging Cohort Study. AIDS Patient Care STDS 25(1):13–20. https://doi.org/10.1089/apc.2010.0242CrossRefPubMedPubMedCentral

Parruti G, Vadini F, Sozio F, Mazzott E, Ursini T, Polill E, Di Stefano P, Tontodonati M, Verrocchio MC, Fulcheri M, Calella G, Santilli F, Manzoli L (2013) Psychological factors, including alexithymia, in the prediction of cardiovascular risk in HIV-infected patients: results of a cohort study. PLoS ONE 8(1):e54555. https://doi.org/10.1371/journal.pone.0054555CrossRefPubMedPubMedCentral

Patterson K, Young C, Woods SP, Vigil O, Grant I, Atkinson JH, The HIV Neurobehavioral Research Center (HNRC) Group (2006) Screening for major depression in persons with HIV infection: the concurrent predictive validity of the Profile of Mood States Depression-Dejection Scale. Int J Methods Psychiatr Res 15(2):75–82. https://doi.org/10.1002/mpr.184CrossRefPubMedPubMedCentral

Petersen KJ, Metcalf N, Cooley S, Tomov D, Vaida F, Paul R, Ances BM (2021) Accelerated brain aging and cerebral blood flow reduction in persons with human immunodeficiency virus. Clin Infect Dis 73(10):1813–1821. https://doi.org/10.1093/cid/ciab169CrossRefPubMedPubMedCentral

Qin P, He J, Yang X, Chen S, Chen X, Jiang H, Fung AWT, Wang Z, Lau JTF (2022) The role of depressive symptoms and physical activity levels in mediating the association between HIV status and neurocognitive functions among individuals aged at least 50 years in China: cross-sectional study. JMIR Public Health Surveill 8(8):e32968. https://doi.org/10.2196/32968CrossRefPubMedPubMedCentral

Rabkin JG (2008) HIV and depression: 2008 review and update. Curr HIV/AIDS Rep 5(4):163–171. https://doi.org/10.1007/s11904-008-0025-1CrossRefPubMed

Rodriguez-Penney AT, Ludicello JE, Riggs PK, Doyle K, Ellis RJ, Letendre SL, Grant I, Woods SP, HIV Neurobehavioral Research Program (HNRP) Group (2013);. Co-morbidities in persons infected with HIV: Increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDS.;27(1):5–16. https://doi.org/10.1089/apc.2012.0329. PMID: 23259908

Roman GC, Jackson RE, Gadhia R, Roman AN, Reis J (2019) Mediterranean diet: The role of long-chain omega-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and Alzheimer disease. Rev Neurol (Paris).;175(10):724–741. https://doi.org/10.1016/j.neurol.2019.08.005. PMID: 31735364

Rooney AS, Moore RC, Paolillo EW, Gouaux B, Umlauf A, Letendre SL, Jeste DV, Moore DJ, Program HINVNRP (2019) Depression and aging with HIV: Associations with health-related quality of life and positive psychological factors. J Affect Disord.;251:1–7. https://doi.org/10.1016/j.jad.2019.03.025. PMID: 30947082

Rubin LH, Benning L, Keating SM, Norris PJ, Burke-Miller J, Savarese A, Kumanan KN, Awadalla S, Springer G, Anastos K, Young M, Milam J, Valcour VG, Weber KM, Maki PM (2018) Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study. J Neurovirol.;24(1):41–51. https://doi.org/10.1007/s13365-017-0590-4. PMID: 28884317

Rubtsova AA, Wingood GM, Ofotokun I, Gustafson D, Vance DE, Sharma A, Adimora AA, Holstad M (2019) Prevalence and correlates of self-rated successful aging among older women living with HIV. J Acquir Immune Defic Syndr.;82(2):S162-S169. https://doi.org/10.1097/QAI.0000000000002175. PMID: 31095099

Saloner R, Campbell LM, Serrano V, Montoya JL, Pasipanodya E, Paolillo EW, Franklin D, Ellis RJ, Letendre SL, Collier AC, Clifford DB, Gelman BB, Marra CM, McCutchan JA, Morgello S, Sacktor N, Jeste DV, Grant I, Heaton RK, Moore DJ et al (2019); CHARTER and HNRP Groups. Neurocognitive SuperAging in older adults living with HIV: Demographic, neuromedical and everyday functioning correlates. J Int Neuropsychol Soc.;25(5):507–519. https://doi.org/10.1017/S1355617719000018. PMID: 30869006

Sheppard DP, Iudicello JE, Bondi MW, Doyle KL, Morgan EE, Massman PJ, Gilbert PE, Woods SP (2015) Elevated rates of mild cognitive impairment in HIV disease. J Neurovirol. b Jul;21(5):576–584. https://doi.org/10.1007/s13365-015-0366-7

Sheppard DP, Iudicello JE, Morgan EE, Kamat R, Clark LR, Avci G, Bondi MW, Woods SP (2017) Accelerated and accentuated neurocognitive aging in HIV infection. J Neurovirol 23(3):492–500. https://doi.org/10.1007/s13365-017-0523-2CrossRefPubMedPubMedCentral

Sheppard DP, Woods SP, Massman PJ, Gilbert PE (2019) Frequency and correlates of subjective cognitive impairment in HIV disease. AIDS Behav.;23(3):617–626. https://doi.org/10.1007/s10461-018-2297-9. PMID: 30362038

Shimizu SM, Chow DC, Valcour V, Masaki K, Nakamoto BK, Kallianpur KJ, Shikuma C (2011) The impact of depressive symptoms of neuropsychological performance tests in HIV-infected individuals: A study of the Hawaii aging with HIV cohort. World J AIDS.;1(4):139–145. https://doi.org/10.4236/wja.2011.14020. PMID: 24244835

Sico JJ, Kundu S, So-Armah K, Gupta SK, Chang CH, Butt AA, Gilbert CL, Marconi VC, Crystal S, Tindle HA, Freiberg MS, Stewart JC (2021) Depression as a risk factor for incident ischemic stroke among HIV-positive veterans in the Veterans Aging Cohort Study. J Am Heart Assoc.;10(13):e017637. https://doi.org/10.1161/JAHA.119.017637. PMID: 34196325

Siedner MJ, Zanni M, Tracy RP, Kwon DS, Tsai AC, Kakuhire B, Hunt PW, Okello S (2018) Increased systemic inflammation and gut permeability among women with treated HIV infection in rural Uganda. J Infect Dis.;218(6):922–926. https://doi.org/10.1093/infdis/jiy244. PMID: 29659786

Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A, de Wolf F, Hallett TB, ATHENA Observational Cohort (2015). Future challenges for clinical care of an ageing population infected with HIV: A modelling study. Lancet Infect Dis.;15:810–818. https://doi.org/10.1016/S1473-3099(15)00056-0. PMID: 25939527

Smith G, Della Sala S, Logie RH, Maylor EA (2000) Sep-Oct;8(5):311–321 Prospective and retrospective memory in normal aging and dementia: A questionnaire study. Memory. doi: 10.1080/09658210050117735. PMID: 11129486

So-Armah K, Benjamin LA, Bloomfield GS, Feinstein MJ, Hsue P, Njuguna B, Freiberg MS (2020) HIV and cardiovascular disease. Lancet HIV.;7(4):e279-e293. https://doi.org/10.1016/S2352-3018(20)30036-9. PMID: 32213354

Stradling C, Thomas GN, Hemming K, Taylor S, Taheri S (2021) Randomized parallel-group pilot trial (Best foods for your heart) comparing the effects of a Mediterranean Portfolio diet with a low saturated fat diet on HIV dyslipidemia. Clin Nutr.;40(3):860–869. doi: 10.1016/j.clnu.2020.08.038. PMID: 32912566

Thompson JL, Sheppard DP, Matchanova A, Morgan EE, Loft S, Woods SP (2022) Subjective cognitive decline disrupts aspects of prospective memory in older adults with HIV disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn.;29(2):308–326. doi: 10.1080/13825585.2022.2065241. PMID: 34564973

Tierney SM, Woods SP, Sheppard D, Ellis RJ (2019) Extrapyramidal motor signs in older adults with HIV disease: Frequency, 1-year course, and associations with activities of daily living and quality of life. J Neurovirol.;25(2):162–173. https://doi.org/10.1007/s13365-018-0699-0. PMID: 30483917

Tomaszewski Farias S, Cahn-Weiner DA, Harvey DJ, Reed BR, Mungas D, Kramer JH, Chui H (2009) Longitudinal changes in memory and executive functioning are associated with longitudinal change in instrumental activities of daily living in older adults. Clin Neuropsychol.;23(3):446–461. doi: 10.1080/13854040802360558. PMID: 18825582

Umegaki H, Sakurai T, Arai H (2021) Active life for brain health: a narrative review of the mechanism underlying the protective effects of physical activity on the brain. Front Aging Neurosci 13:761674. https://doi.org/10.3389/fnagi.2021.761674PMID: 34744712; PMCID: PMC8577836CrossRefPubMedPubMedCentral

Valcour V, Shikuma C, Shiramizu B, Poff P, Selnes O, Holck P, Grove J, Sacktor N (2004) Higher frequency of dementia in older HIV-1 individuals: The Hawaii aging with HIV-1 cohort. Neurology.;63(5):822–827. https://doi.org/10.1212/01.wnl.0000134665.58343.8d. PMID: 15365146

Vance DE, Lee Y, Batey DS, Li W, Chapman Lambert C, Nakkina SR, Anderson JN, Triebel K, Byun JY, Fazeli PL (2022) Emerging directions of cognitive aging with HIV: Practice and policy implications for social work. J Gerontol Soc Work.;65(5):476–494. doi: 10.1080/01634372.2021.1978028. PMID: 34607157

Vance DE, Blake BJ, Brennan-Ing M, DeMarco RF, Fazeli PL, Relf MV Revisiting successful aging with HIV through a revised biopsychosocial model: An update of the literature. J Assoc Nurses AIDS Care. 2019 Jan-Feb;30(1):5–14. https://doi.org/10.1097/jnc.0000000000000029. PMID: 30201333

Wallace LMK, Ferrara M, Brothers TD, Garlassi S, Kirkland SA, Theou O, Zona S, Mussini C, Moore D, Rockwood K, Guaraldi G (2017) Physical frailty and risk of cognitive impairment in HIV-infected individuals. AIDS Res Hum Retroviruses 33(2):157–163. https://doi.org/10.1089/aid.2016.0189PMID: 27575336; PMCID: PMC5295277CrossRefPubMedPubMedCentral

Woods SP, Dawson MS, Weber E, Grant I, HIV Neurobehavioral Research Center (HNRC) Group (2010) The semantic relatedness of cue-intention pairings influences event-based prospective memory failures in older adults with HIV infection. J Clin Exp Neuropsychol 32(4):398–407 PMID: 19941122; PMCID: PMC2872461CrossRefPubMed

Woods SP, Morgan EE, Loft S, Matchanova A, Verduzco M, Cushman C (2020) Supporting strategic processes can improve time-based prospective memory in the laboratory among older adults with HIV disease. Neuropsychology 34(3):249–263. https://doi.org/10.1037/neu0000602PMID: 31724434; PMCID: PMC7107274CrossRefPubMed

World Health Organization (WHO) (1998) Composite international diagnostic interview (CIDI, version 2.128). World Health Organization, Geneva, Switzerland

Titel: Implications of vascular depression for successful cognitive aging in HIV Disease
verfasst von: Andrea I. Mustafa
Ilex Beltran-Najera
Darrian Evans
Alexandria Bartlett
Vonetta M. Dotson
Steven Paul Woods
Publikationsdatum: 28.03.2024
Verlag: Springer International Publishing
Erschienen in: Journal of NeuroVirology / Ausgabe 2/2024
Print ISSN: 1355-0284
Elektronische ISSN: 1538-2443
DOI: https://doi.org/10.1007/s13365-024-01201-2

RNA-Seq time-course analysis of neural precursor cell transcriptome in response to herpes simplex Virus-1 infection

Open Access

The synergistic effect of insomnia and depression on risk of herpes zoster

Cerebrospinal Fluid Biomarkers of Symptomatic Neurosyphilis in People With HIV Compared with Uninfected Individuals

Catastrophic tumefactive acute disseminated encephalomyelitis in patient with dengue virus: a case report

Case Report

Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) study

Open Access

Spinal cord involvement in progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome

Case Report

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Neuartige Antikörpertherapie bremst MS über zwei Jahre hinweg

18.04.2025
AAN-Jahrestagung 2025
Nachrichten

Eine Therapie mit dem C40-Ligand-Blocker Frexalimab kann MS-Schübe und neue MRT-Läsionen über zwei Jahre hinweg verhindern. Dafür spricht die Auswertung einer offen fortgeführten Phase-2-Studie.

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

17.04.2025
AAN-Jahrestagung 2025
Kongressbericht

Eine auf das B-Zell-Reifungsantigen gerichtete mRNA-basierte CAR-T-Zell-Therapie wurde jetzt in einer ersten Phase IIb-Studie zur Behandlung der generalisierten Myasthenia gravis mit Placebo verglichen.

Therapiestopp bei älteren MS-Kranken kann sich lohnen

17.04.2025
AAN-Jahrestagung 2025
Nachrichten

Eine Analyse aus Kanada bestätigt: Setzen ältere MS-Kranke die Behandlung mit Basistherapeutika ab, müssen sie kaum mit neuen Schüben und MRT-Auffälligkeiten rechnen.

Schadet Schichtarbeit dem Gehirn?

17.04.2025
AAN-Jahrestagung 2025
Kongressbericht

Eine große Registerstudie bestätigt, dass Schichtarbeit mit einem erhöhten Risiko für psychische und neurologische Erkrankungen einhergeht, sowie mit einer Volumenabnahme in Gehirnarealen, die für Depression, Angst und kognitive Funktionen relevant sind.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Implications of vascular depression for successful cognitive aging in HIV Disease

Abstract

Weitere Artikel der Ausgabe 2/2024

RNA-Seq time-course analysis of neural precursor cell transcriptome in response to herpes simplex Virus-1 infection

The synergistic effect of insomnia and depression on risk of herpes zoster

Cerebrospinal Fluid Biomarkers of Symptomatic Neurosyphilis in People With HIV Compared with Uninfected Individuals

Catastrophic tumefactive acute disseminated encephalomyelitis in patient with dengue virus: a case report

Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) study

Spinal cord involvement in progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Neu im Fachgebiet Neurologie

Neuartige Antikörpertherapie bremst MS über zwei Jahre hinweg

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

Therapiestopp bei älteren MS-Kranken kann sich lohnen

Schadet Schichtarbeit dem Gehirn?

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten